Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

The soluble urokinase-type plasminogen activator receptor (suPAR) has recently been associated with a decline in kidney function and incidence of chronic kidney disease in patients with cardiovascular disease undergoing cardiac catheterization, yet little is known whether suPAR is associated with de...

Full description

Bibliographic Details
Main Authors: Christina-Alexandra Schulz, Margaretha Persson, Anders Christensson, George Hindy, Peter Almgren, Peter M. Nilsson, Olle Melander, Gunnar Engström, Marju Orho-Melander
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Kidney International Reports
Subjects:
chronic kidney disease
renal function
suPAR
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024916301693

Internet

http://www.sciencedirect.com/science/article/pii/S2468024916301693

Similar Items